4Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries. Canada and the United States. Hypertension, 2004,43 ( 1 ) : 10-17.
5Cardiovascular Morbidity and Mortality in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol. Lancet, 2002,359 (9312) :995- 1003.
6Julius S, Kjeldsen SE, Brunner H, et al. VALUE trial: Longterm blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk. Am J Hypertens, 2003,16(7) :544- 548.
8American Society of Hypertension Annual Meeting: San Francisco. 14-18 May, 2005.
9Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs Diuretic (ALLHAT). The ALLHAT officers and coordinators for the ALLHAT collaborative research group. JAMA, 2002,288 (23) :2981-2997.
10Gu D, Gupta A, Muntner P, et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia ( InterAsia). Circulation, 2005, 112 ( 5 ) : 658- 665.
